Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypertrophic cardiomyopathy: presentation and pathophysiology

S Lerakis1, R G Sheahan, G A Stouffer

  • 1Department of Medicine, University of Texas Medical Branch, Galveston 77555-1064, USA.

The American Journal of the Medical Sciences
|November 20, 1997
PubMed
Summary

Hypertrophic cardiomyopathy (HCM) is complex, but genetic insights improve diagnosis and risk stratification for cardiovascular mortality. New treatments are emerging, requiring clinical trials for optimal patient care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Unravelling the reality of COVID-19 cardiovascular complications: true myocarditis vs. myocardial injury-the role of a multilayered approach.

Frontiers in cardiovascular medicine·2024
Same author

Evaluating cardioversion outcomes for atrial fibrillation on novel oral anticoagulants versus warfarin: experience at a tertiary referral centre.

Irish journal of medical science·2017
Same author

Catheter-based renal denervation in the treatment of resistant hypertension.

Journal of molecular and cellular cardiology·2013
Same author

Epicardial and pericardial adipose tissue: physiological importance and role of imaging techniques.

Minerva cardioangiologica·2012
Same author

Hemodynamic findings in severe tricuspid regurgitation.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2012
Same author

Unilateral renal artery stenosis causes a chronic vascular inflammatory response in ApoE-/- mice.

Transactions of the American Clinical and Climatological Association·2010

Area of Science:

  • Cardiology
  • Genetics
  • Internal Medicine

Background:

  • Hypertrophic cardiomyopathy (HCM) presents heterogeneously with diverse clinical manifestations.
  • Understanding the genetic basis of ventricular hypertrophy is advancing diagnostic capabilities.

Observation:

  • Genetic discoveries aid in identifying patient subgroups at high risk for cardiovascular mortality.
  • Challenges persist in managing HCM symptoms and preventing sudden cardiac death (SCD).

Findings:

  • Several novel therapeutic strategies for HCM are currently under investigation.
  • New treatment options aim to improve symptom relief and reduce mortality risk.

Implications:

  • Future randomized trials are essential to compare major HCM interventions.

Related Experiment Videos

  • Evidence-based guidance is needed for optimal treatment strategies, including pharmacologic therapy and surgical/interventional procedures.